
ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoin... ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.08 | 1.14777618364 | 6.97 | 7.42 | 6.67 | 441591 | 7.11511708 | CS |
4 | -0.69 | -8.91472868217 | 7.74 | 7.85 | 6.67 | 297542 | 7.18916406 | CS |
12 | -0.7 | -9.03225806452 | 7.75 | 8.31 | 6.67 | 349908 | 7.48334633 | CS |
26 | -7.95 | -53 | 15 | 17.63 | 6.67 | 533282 | 9.4521527 | CS |
52 | -4.83 | -40.6565656566 | 11.88 | 18.75 | 6.67 | 448650 | 11.85591105 | CS |
156 | -26.57 | -79.0303390839 | 33.62 | 37.26 | 6.67 | 394166 | 15.40969494 | CS |
260 | -12.65 | -64.2131979695 | 19.7 | 52.43 | 6.67 | 359124 | 19.99953742 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.